Blog
Retatrutide 101: What Consumers Should Know About the Growing Online Market
Interest in next-generation obesity medicines is accelerating rapidly — and so is the online marketplace claiming to sell them. One of the latest examples is retatrutide, an investigational therapy currently being studied in clinical trials but increasingly promoted online through wellness...
National Consumers League Commends FDA for Swift Action Against Hims & Hers
Media Contact: Lisa McDonald, Vice President of Communications, 202-207-2829 Washington, DC – You can fool some of the people some of the time and all of the people some of the time. But you can’t fool all of the people all the time. On Friday, February 6, the Food and Drug Administration...
Impurity Found in Compounded GLP-1 Drugs Underscores Importance of FDA Oversight
Philip Schneider, MS FASHP FFIP As a pharmacist, my priority is helping patients benefit from medicines, and protect them from harm caused by medicines intended to help them. This week we saw an example of why the oversight of the U.S. Food and Drug Administration (FDA) is so important in this...
Caught in the Middle? Not!
As a pharmacist, one could imagine that the issue of compounding a medicine for which there is widespread patient need would be an opportunity, not a problem. Pharmacists of a “certain age” spent a lot of time when we were in pharmacy school in the compounding lab learning how to perform a...
Receive News Alerts
Sign up to get the latest updates straight to your inbox.
The Alliance for Safe Biologic Medicines (ASBM) is a diverse coalition of stakeholders, including physicians, pharmacists, patient advocates, researchers, and biopharmaceutical manufacturers. Since 2010, ASBM has worked with regulators worldwide to shape policies that reflect the best interests of patients, ensuring access to lifesaving and life-enhancing medicines while fostering innovation in healthcare.